<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>46</volume><submitter>Seo Y</submitter><funding>Korea Disease Control and Prevention Agency</funding><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Cardiovascular diseases are a leading cause of mortality worldwide, and acute myocardial infarction (AMI) is particularly fatal condition. We evaluated the incidence and case fatality rates of AMI in Korea from 2011 to 2020.&lt;h4>Methods&lt;/h4>We utilized data from the National Health Insurance Services to calculate crude, age-standardized, and age-specific incidence rates, along with 30-day and 1-year case fatality rates, of AMI from 2011 to 2020. Age-standardized incidence rates were determined using direct standardization to the 2005 population.&lt;h4>Results&lt;/h4>The crude incidence rate of AMI per 100,000 person-years consistently increased from 44.7 in 2011 to 68.3 in 2019, before decreasing slightly to 66.2 in 2020. The age-standardized incidence rate of AMI displayed a 19% rise from 2011 to 2019, followed by a slight decline in 2020. The increasing trend for AMI incidence was more pronounced in males than in females. Both 30-day and 1-year case fatality rates remained stable among younger individuals but showed a decrease among older individuals. There was a minor surge in case fatality in 2020, particularly among recurrent AMI cases.&lt;h4>Conclusions&lt;/h4>Over the past decade, the AMI incidence rate in Korea has consistently increased, with a slight downturn in 2020. The case fatality rate has remained relatively stable except for a minor increase in 2020. This study provides data for continuous surveillance, the implementation of targeted interventions, and the advancement of research aimed at AMI in Korea.</pubmed_abstract><journal>Epidemiology and health</journal><pagination>e2024002</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10928467</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Incidence and case fatality of acute myocardial infarction in Korea, 2011-2020.</pubmed_title><pmcid>PMC10928467</pmcid><pubmed_authors>Shin S</pubmed_authors><pubmed_authors>Bae JW</pubmed_authors><pubmed_authors>Lee SJ</pubmed_authors><pubmed_authors>Kim E</pubmed_authors><pubmed_authors>Seo Y</pubmed_authors><pubmed_authors>Lee HH</pubmed_authors><pubmed_authors>Kim HC</pubmed_authors><pubmed_authors>Lee H</pubmed_authors><pubmed_authors>Kaneko F</pubmed_authors><pubmed_authors>Moon J</pubmed_authors><pubmed_authors>Kim M</pubmed_authors><pubmed_authors>Kim BK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Incidence and case fatality of acute myocardial infarction in Korea, 2011-2020.</name><description>&lt;h4>Objectives&lt;/h4>Cardiovascular diseases are a leading cause of mortality worldwide, and acute myocardial infarction (AMI) is particularly fatal condition. We evaluated the incidence and case fatality rates of AMI in Korea from 2011 to 2020.&lt;h4>Methods&lt;/h4>We utilized data from the National Health Insurance Services to calculate crude, age-standardized, and age-specific incidence rates, along with 30-day and 1-year case fatality rates, of AMI from 2011 to 2020. Age-standardized incidence rates were determined using direct standardization to the 2005 population.&lt;h4>Results&lt;/h4>The crude incidence rate of AMI per 100,000 person-years consistently increased from 44.7 in 2011 to 68.3 in 2019, before decreasing slightly to 66.2 in 2020. The age-standardized incidence rate of AMI displayed a 19% rise from 2011 to 2019, followed by a slight decline in 2020. The increasing trend for AMI incidence was more pronounced in males than in females. Both 30-day and 1-year case fatality rates remained stable among younger individuals but showed a decrease among older individuals. There was a minor surge in case fatality in 2020, particularly among recurrent AMI cases.&lt;h4>Conclusions&lt;/h4>Over the past decade, the AMI incidence rate in Korea has consistently increased, with a slight downturn in 2020. The case fatality rate has remained relatively stable except for a minor increase in 2020. This study provides data for continuous surveillance, the implementation of targeted interventions, and the advancement of research aimed at AMI in Korea.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2026-06-25T03:13:57.273Z</modification><creation>2025-04-04T21:31:02.02Z</creation></dates><accession>S-EPMC10928467</accession><cross_references><pubmed>38186244</pubmed><doi>10.4178/epih.e2024002</doi></cross_references></HashMap>